N
Neurizer Ltd
ASX:NRZ
Neurizer Ltd
ASX:NRZ
Price:
0.001
AUD
Market Closed
Market Cap:
AU$3.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
N
|
Neurizer Ltd
ASX:NRZ
|
AU |
|
Novo Nordisk A/S
NYSE:NVO
|
DK |
|
S
|
Shanghai International Shanghai Growth Investment Ltd
HKEX:770
|
HK |
|
T&D Holdings Inc
TSE:8795
|
JP |
|
S
|
Stefanutti Stocks Holdings Ltd
JSE:SSK
|
ZA |
|
A
|
Amplifon SpA
LSE:0N61
|
IT |
|
V
|
Vinacomin Coc Sau Coal JSC
VN:TC6
|
VN |
|
S
|
Stereotaxis Inc
F:RJR1
|
US |
|
S
|
Saigon Hanoi Securities JSC
VN:SHS
|
VN |
|
M
|
Mayinglong Pharmaceutical Group Co Ltd
SSE:600993
|
CN |
|
X
|
X Fab Silicon Foundries EV
OTC:XFABF
|
BE |
|
P
|
Priya Ltd
BSE:524580
|
IN |
|
GMB Korea Corp
KRX:013870
|
KR |
|
Peyto Exploration & Development Corp
TSX:PEY
|
CA |
|
Crealogix Holding AG
SIX:CLXN
|
CH |
Income Statement
Earnings Waterfall
Neurizer Ltd
Neurizer Ltd
Income Statement
Neurizer Ltd
Neurizer Ltd
Currency: AUD
| Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
+100%
|
0
-6%
|
0
+324%
|
0
-1%
|
0
N/A
|
0
N/A
|
|
| Gross Profit | |||||||||
| Cost of Revenue |
(4)
|
(7)
|
(8)
|
(10)
|
(8)
|
(3)
|
(2)
|
(2)
|
|
| Gross Profit |
(4)
N/A
|
(7)
-48%
|
(8)
-26%
|
(10)
-24%
|
(8)
+17%
|
(3)
+66%
|
(2)
+29%
|
(2)
-17%
|
|
| Operating Income | |||||||||
| Operating Expenses |
(5)
|
(5)
|
(4)
|
(5)
|
(5)
|
(1)
|
(1)
|
(1)
|
|
| Selling, General & Administrative |
(4)
|
0
|
(0)
|
0
|
(2)
|
1
|
0
|
0
|
|
| Depreciation & Amortization |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Operating Expenses |
(0)
|
(4)
|
(4)
|
(5)
|
(3)
|
(3)
|
(1)
|
(1)
|
|
| Operating Income |
(9)
N/A
|
(11)
-24%
|
(12)
-13%
|
(15)
-21%
|
(14)
+10%
|
(4)
+68%
|
(3)
+40%
|
(3)
-32%
|
|
| Pre-Tax Income | |||||||||
| Interest Income Expense |
(0)
|
(7)
|
(0)
|
(7)
|
(2)
|
(3)
|
(3)
|
(4)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
(5)
|
(0)
|
(8)
|
0
|
(1)
|
1
|
0
|
0
|
|
| Pre-Tax Income |
(14)
N/A
|
(18)
-30%
|
(20)
-16%
|
(22)
-6%
|
(16)
+25%
|
(8)
+53%
|
(6)
+27%
|
(8)
-40%
|
|
| Net Income | |||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(14)
|
(18)
|
(20)
|
(22)
|
(16)
|
(8)
|
(6)
|
(8)
|
|
| Net Income (Common) |
(14)
N/A
|
(18)
-30%
|
(20)
-16%
|
(22)
-6%
|
(16)
+25%
|
(8)
+53%
|
(6)
+27%
|
(8)
-40%
|
|
| EPS (Diluted) |
-0.02
N/A
|
-0.02
N/A
|
-0.02
N/A
|
-0.02
N/A
|
-0.02
N/A
|
-0.01
+50%
|
0
N/A
|
0
N/A
|
|
Switch to:
Switch to:
See Also
Discover More
